PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside

AS Alzahrani - Seminars in cancer biology, 2019 - Elsevier
Abstract Phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR)
signaling pathway is one of the major cellular signaling pathways that plays an important …

PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside

AS Alzahrani - Seminars in cancer biology, 2019 - pubmed.ncbi.nlm.nih.gov
Phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) signaling
pathway is one of the major cellular signaling pathways that plays an important role in basic …

PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside.

AS Alzahrani - Seminars in Cancer Biology, 2019 - europepmc.org
Phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) signaling
pathway is one of the major cellular signaling pathways that plays an important role in basic …

[引用][C] PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside

AS Alzahrani - Seminars in Cancer Biology, 2019 - cir.nii.ac.jp